Personalized Blood Test to Help Selection of Lung Cancer Treatment
University of Cambridge has led a study that showed that a personalized blood test performed after lung cancer treatment could
Everything about lung cancer is here.
University of Cambridge has led a study that showed that a personalized blood test performed after lung cancer treatment could
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for
The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab
In the arena of lung cancer, new researches and studies are being carried out all around the world to help
There are two predominant types of lung cancer: small cell lung cancer and non-small cell lung cancer. NSCLC accounts for
European Commission (EC) has granted marketing authorization for Lorviqua as monotherapy for treatment of patients with anaplastic lymphoma kinase (ALK)